SkyView Investment Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$107K Buy
+2,500
New +$136K 0.08% 162
2023
Q3
– Sell
-5,473
Closed -$296K – 617
2023
Q2
$296K Sell
5,473
-1,164
-18% -$60.8K 0.07% 317
2023
Q1
$332K Buy
6,637
+12
+0.2% +$566 0.08% 287
2022
Q4
$307K Buy
6,625
+91
+1% +$3.94K 0.09% 274
2022
Q3
$253K Sell
6,534
-279
-4% -$11.2K 0.07% 331
2022
Q2
$254K Sell
6,813
-10,144
-60% -$413K 0.07% 354
2022
Q1
$731K Buy
16,957
+8,421
+99% +$365K 0.17% 178
2021
Q4
$674K Buy
+8,536
New +$359K 0.15% 174

Other funds holding BSX

SkyView Investment Advisors's BSX Position: Q2 2026 in Review

SkyView Investment Advisors opened a new position in Boston Scientific (BSX) in Q2 2026: 2,500 shares worth $107K. The stake represents 0.08% of the portfolio and ranks #162 among its holdings. This is a return to the name: SkyView Investment Advisors previously reported a position in BSX as recently as Q2 2023.

SkyView Investment Advisors first reported a position in BSX in Q4 2021 and has held it in 8 quarters since. The position peaked at $731K in Q1 2022. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • SkyView Investment Advisors held 2,500 shares of Boston Scientific worth $107K as of Q2 2026.
  • Boston Scientific was a new SkyView Investment Advisors position in Q2 2026.
  • Boston Scientific made up 0.08% of SkyView Investment Advisors's portfolio in Q2 2026, its #162 holding.
  • SkyView Investment Advisors first reported a position in Boston Scientific in Q4 2021 and has held it in 8 quarters since.
  • SkyView Investment Advisors's Boston Scientific position peaked at $731K in Q1 2022.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on SkyView Investment Advisors's 13F filing for Q2 2026, filed 15 Sep 2026.